GoKawiilAstraZeneca signs up to $1.5B AI drug discovery deal with Insitro
AstraZeneca has agreed to pay AI-driven biotech company Insitro $40 million upfront, with potential milestone payments bringing the total deal value to as much as $1.46 billion. The partnership centers on using Insitro's machine learning platform for drug discovery.